Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intravenous sildenafil reduces pulmonary
artery pressure and improves oxygenation in near-term and term infants with persistent
pulmonary hypertension.
Phase:
Phase 2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborators:
Ann & Robert H Lurie Children's Hospital of Chicago National Heart, Lung, and Blood Institute (NHLBI) State University of New York at Buffalo University of Alabama at Birmingham University of Utah Vanderbilt University